We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
RPL35A
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • RPL35A
CANCER OVARIAN CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
OV TCGA OV VALIDATION PROTEIN OV CPTAC
Dictionary
Ovarian cancer
Human cancer
Ovary serous cystadenocarcinoma
OVARY SEROUS CYSTADENOCARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

RPL35A is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)


Stage:

Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 2267
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 1824.0
Number of samples 349
Samples
Sample Description pTPM
TCGA-23-1022-01A 67 years, female, white, stage:Stage IIIC, dead, 1511 days 5874.1
TCGA-04-1343-01A 72 years, female, white, stage:Stage IV, dead, 361 days 5664.5
TCGA-04-1347-01A 81 years, female, white, stage:Stage IV, alive, 1919 days 5514.9
TCGA-09-2048-01A 63 years, female, white, stage:Stage IIIC, dead, 138 days 5408.4
TCGA-13-0724-01A 72 years, female, white, stage:Stage IV, dead, 83 days 5270.9
TCGA-29-2425-01A 60 years, female, white, stage:Stage IIIC, alive, 1977 days 5056.8
TCGA-29-1777-01A 47 years, female, white, stage:Stage IIIC, alive, 374 days 4918.5
TCGA-13-1487-01A 74 years, female, white, stage:Stage IV, dead, 681 days 4626.5
TCGA-04-1350-01A 46 years, female, white, stage:Stage IIIC, dead, 1946 days 4602.5
TCGA-13-1409-01A 73 years, female, white, stage:Stage IIIC, dead, 1742 days 4562.9
TCGA-13-1489-01A 70 years, female, white, stage:Stage IIIC, dead, 2553 days 4443.0
TCGA-13-0795-01A 66 years, female, white, stage:Stage IIIC, dead, 619 days 4261.8
TCGA-04-1655-01A 49 years, female, white, stage:Stage IIIB, dead, 1380 days 4020.7
TCGA-29-1703-01A 56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days 4015.1
TCGA-23-1107-01A 59 years, female, white, stage:Stage IV, dead, 9 days 3910.4
TCGA-30-1714-01A 68 years, female, white, stage:Stage IV, dead, 1158 days 3900.3
TCGA-10-0937-01A 44 years, female, white, stage:Stage IIIC, dead, 608 days 3868.7
TCGA-29-2414-01A 75 years, female, white, stage:Stage IIIC, dead, 2621 days 3680.5
TCGA-24-1846-01A 45 years, female, stage:Stage IIIC, alive, 133 days 3668.6
TCGA-61-2009-01A 65 years, female, white, stage:Stage IIIC, alive, 1212 days 3668.6
TCGA-24-2038-01A 68 years, female, white, stage:Stage IIIA, dead, 1354 days 3661.5
TCGA-59-A5PD-01A 55 years, female, black or african american, stage:Stage IC, dead, 624 days 3644.2
TCGA-29-1766-01A 74 years, female, white, stage:Stage IIIC, dead, 1199 days 3622.8
TCGA-13-0804-01A 73 years, female, white, stage:Stage IIIC, dead, 1073 days 3534.7
TCGA-29-1693-01A 72 years, female, white, stage:Stage IIIC, alive, 3096 days 3534.6
TCGA-24-1562-01A 67 years, female, white, stage:Stage IIIC, dead, 1384 days 3489.9
TCGA-61-2008-01A 40 years, female, asian, stage:Stage IIC, alive, 932 days 3453.6
TCGA-61-1733-01A 71 years, female, white, stage:Stage IIIC, alive, 967 days 3405.6
TCGA-13-0888-01A 78 years, female, white, stage:Stage IIIC, dead, 2811 days 3372.1
TCGA-04-1542-01A 52 years, female, white, stage:Stage IIIB, dead, 2561 days 3355.2
TCGA-25-2393-01A 81 years, female, white, stage:Stage IIIC, dead, 1157 days 3267.2
TCGA-61-1998-01A 48 years, female, white, stage:Stage IIIC, alive, 168 days 3254.6
TCGA-61-1721-01A 38 years, female, white, stage:Stage IV, alive, 338 days 3249.1
TCGA-13-0727-01A 71 years, female, white, stage:Stage IIIC, dead, 462 days 3244.2
TCGA-04-1341-01A 85 years, female, white, stage:'--, alive, 33 days 3129.1
TCGA-10-0928-01A 71 years, female, white, stage:Stage IIIC, dead, 563 days 3109.4
TCGA-13-0765-01A 50 years, female, white, stage:Stage IIIC, dead, 1389 days 3082.1
TCGA-23-1118-01A 45 years, female, white, stage:Stage IIIC, alive, 2616 days 3024.4
TCGA-23-1109-01A 62 years, female, white, stage:Stage IIIC, dead, 1562 days 3002.3
TCGA-24-1471-01A 60 years, female, white, stage:Stage IIIC, alive, 36 days 2977.9
TCGA-24-0982-01A 77 years, female, white, stage:Stage IIIC, dead, 679 days 2958.3
TCGA-29-1761-01A 80 years, female, asian, stage:Stage IIIC, dead, 528 days 2958.2
TCGA-29-1776-01A 63 years, female, black or african american, stage:Stage IIIC, alive, 360 days 2953.2
TCGA-61-1724-01A 47 years, female, white, stage:Stage IIIC, dead, 637 days 2916.9
TCGA-25-1870-01A 59 years, female, white, stage:Stage IIIC, dead, 455 days 2914.7
TCGA-29-1701-01A 56 years, female, white, stage:Stage IIIC, dead, 515 days 2911.6
TCGA-10-0927-01A 65 years, female, stage:Stage IIIC, dead, 2490 days 2909.4
TCGA-23-1113-01A 48 years, female, white, stage:Stage IV, dead, 949 days 2904.9
TCGA-24-0966-01A 78 years, female, black or african american, stage:Stage IIIC, alive, 232 days 2903.9
TCGA-23-1119-01A 64 years, female, white, stage:Stage IIIC, alive, 3953 days 2887.2
TCGA-59-2355-01A 58 years, female, white, stage:Stage IV, dead, 65 days 2878.5
TCGA-30-1853-01A 58 years, female, white, stage:Stage IIIC, dead, 1103 days 2878.3
TCGA-13-0725-01A 44 years, female, white, stage:Stage IIIC, dead, 377 days 2851.6
TCGA-25-1634-01A 75 years, female, white, stage:Stage IIIC, dead, 1091 days 2824.7
TCGA-13-1404-01A 48 years, female, white, stage:Stage IIIC, alive, 2469 days 2769.6
TCGA-29-1696-01A 43 years, female, white, stage:Stage IIIC, dead, 1032 days 2768.9
TCGA-13-1510-01A 62 years, female, white, stage:Stage IIIC, dead, 1359 days 2740.6
TCGA-04-1356-01A 62 years, female, white, stage:Stage IIC, dead, 1499 days 2739.7
TCGA-04-1338-01A 78 years, female, white, stage:Stage IIIC, alive, 1418 days 2700.9
TCGA-09-1670-01A 57 years, female, white, stage:Stage IIIA, alive, 547 days 2692.4
TCGA-13-1507-01A 77 years, female, white, stage:Stage IIIC, dead, 1993 days 2657.6
TCGA-61-2000-01A 67 years, female, white, stage:Stage IIIC, alive, 441 days 2650.1
TCGA-61-1741-01A 76 years, female, white, stage:Stage IIIB, dead, 1024 days 2640.1
TCGA-04-1651-01A 53 years, female, white, stage:Stage IIIC, dead, 1102 days 2637.2
TCGA-09-0367-01A 67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days 2614.1
TCGA-23-1027-01A 48 years, female, white, stage:Stage IIIC, dead, 976 days 2609.7
TCGA-13-1488-01A 59 years, female, white, stage:Stage IV, dead, 2154 days 2589.0
TCGA-VG-A8LO-01A 55 years, female, black or african american, stage:Stage IV, dead, 24 days 2562.6
TCGA-13-1506-01A 45 years, female, white, stage:Stage IIIC, dead, 1039 days 2557.3
TCGA-23-2077-01A 45 years, female, white, stage:Stage IIIC, alive, 3525 days 2544.6
TCGA-10-0938-01A 80 years, female, white, stage:Stage IIIC, dead, 636 days 2544.2
TCGA-24-0979-01A 53 years, female, white, stage:Stage IV, dead, 1264 days 2521.2
TCGA-25-1877-01A 81 years, female, white, stage:Stage IIIC, dead, 730 days 2463.3
TCGA-13-1496-01A 65 years, female, white, stage:Stage IIIC, dead, 129 days 2457.8
TCGA-61-1914-01A 65 years, female, stage:Stage IIIC, alive, 1722 days 2419.7
TCGA-13-1498-01A 73 years, female, white, stage:Stage IIIC, dead, 2012 days 2409.8
TCGA-24-1464-01A 70 years, female, white, stage:Stage IIIC, dead, 379 days 2398.9
TCGA-30-1891-01A 61 years, female, white, stage:Stage IIIC, dead, 914 days 2397.1
TCGA-57-1586-01A 66 years, female, white, stage:Stage IIIC, alive, 679 days 2383.4
TCGA-25-2396-01A 71 years, female, white, stage:Stage IIIC, dead, 92 days 2354.6
TCGA-23-1028-01A 43 years, female, white, stage:Stage IIIC, alive, 1503 days 2333.8
TCGA-09-0369-01A 56 years, female, white, stage:Stage IIIC, dead, 1082 days 2327.0
TCGA-13-0911-01A 55 years, female, white, stage:Stage IV, dead, 1355 days 2322.6
TCGA-36-1577-01A 43 years, female, asian, stage:Stage IIC, alive, 783 days 2291.4
TCGA-24-1544-01A 71 years, female, black or african american, stage:Stage IIIC, dead, 820 days 2270.7
TCGA-13-1495-01A 60 years, female, white, stage:Stage IIIC, dead, 2749 days 2263.3
TCGA-29-2428-01A 58 years, female, white, stage:Stage IIIC, alive, 1372 days 2262.3
TCGA-13-1497-01A 47 years, female, white, stage:Stage IIIC, alive, 3871 days 2258.2
TCGA-OY-A56Q-01A 78 years, female, black or african american, stage:Stage IIA, alive, 576 days 2256.8
TCGA-13-0726-01A 55 years, female, white, stage:Stage IIIC, dead, 949 days 2211.6
TCGA-29-1769-01A 40 years, female, white, stage:Stage IIIC, alive, 699 days 2210.1
TCGA-61-1911-01A 55 years, female, white, stage:Stage IIA, alive, 1293 days 2203.4
TCGA-09-1669-01A 54 years, female, white, stage:Stage IIIA, alive, 928 days 2202.0
TCGA-25-1316-01A 55 years, female, white, stage:Stage IIIC, dead, 1279 days 2195.2
TCGA-24-1426-01A 43 years, female, white, stage:Stage IIIC, alive, 163 days 2195.1
TCGA-24-1845-01A 42 years, female, white, stage:Stage IIIC, alive, 116 days 2175.5
TCGA-13-0924-01A 45 years, female, white, stage:Stage IV, alive, 2614 days 2167.7
TCGA-10-0933-01A 77 years, female, white, stage:Stage IIIC, dead, 446 days 2146.2
TCGA-59-2363-01A 40 years, female, asian, stage:Stage IIIA, alive, 165 days 2134.1
TCGA-13-0762-01A 65 years, female, white, stage:Stage IIIC, alive, 3400 days 2132.9
TCGA-24-1550-01A 49 years, female, white, stage:Stage IIIC, dead, 1249 days 2132.5
TCGA-25-1317-01A 66 years, female, white, stage:Stage IIIC, dead, 61 days 2113.4
TCGA-13-1509-01A 64 years, female, white, stage:Stage IV, alive, 2438 days 2108.4
TCGA-13-0891-01A 73 years, female, white, stage:Stage IV, dead, 3128 days 2100.7
TCGA-61-2110-01A 56 years, female, white, stage:Stage IIIC, dead, 1354 days 2099.3
TCGA-13-0897-01A 54 years, female, white, stage:Stage IIIC, dead, 2182 days 2088.6
TCGA-25-1323-01A 72 years, female, white, stage:Stage IIIC, dead, 395 days 2065.3
TCGA-61-1725-01A 40 years, female, white, stage:Stage IIIC, alive, 956 days 2061.7
TCGA-61-2002-01A 46 years, female, white, stage:Stage IIIC, alive, 547 days 2049.8
TCGA-24-1923-01A 51 years, female, white, stage:Stage IIIC, dead, 690 days 2036.0
TCGA-09-2051-01A 42 years, female, white, stage:Stage IIIC, alive, 1919 days 2034.4
TCGA-10-0931-01A 44 years, female, white, stage:Stage IIIC, dead, 1000 days 2033.3
TCGA-24-1560-01A 51 years, female, white, stage:Stage IIIC, dead, 1341 days 2023.7
TCGA-30-1892-01A 52 years, female, white, stage:Stage IIIC, dead, 1484 days 2013.0
TCGA-13-1407-01A 51 years, female, white, stage:Stage IIIC, alive, 2534 days 2002.3
TCGA-23-1024-01A 52 years, female, white, stage:Stage IV, alive, 468 days 1996.1
TCGA-09-0364-01A 80 years, female, white, stage:Stage IIC, dead, 887 days 1990.2
TCGA-13-1477-01A 49 years, female, white, stage:Stage IV, dead, 1662 days 1982.7
TCGA-13-0887-01A 42 years, female, white, stage:Stage IIIC, dead, 2028 days 1976.3
TCGA-20-0991-01A 78 years, female, white, stage:Stage IIB, alive, 797 days 1958.9
TCGA-31-1946-01A 30 years, female, stage:Stage IIIC, alive, 918 days 1949.4
TCGA-13-0766-01A 42 years, female, white, stage:Stage IIIC, dead, 1725 days 1944.7
TCGA-20-1687-01A 46 years, female, white, stage:Stage IV, alive, 81 days 1930.4
TCGA-24-1553-01A 53 years, female, white, stage:Stage IIIB, dead, 1767 days 1926.6
TCGA-24-1567-01A 54 years, female, white, stage:Stage IIIB, dead, 524 days 1919.3
TCGA-04-1365-01A 87 years, female, white, stage:Stage IIIB, alive, 947 days 1915.0
TCGA-5X-AA5U-01A 61 years, female, black or african american, stage:Stage IIC, alive, 361 days 1905.4
TCGA-36-1569-01A 52 years, female, white, stage:Stage IIIC, alive, 885 days 1888.9
TCGA-04-1530-01A 68 years, female, white, stage:Stage IIIC, dead, 3622 days 1885.8
TCGA-29-1778-01A 77 years, female, white, stage:Stage IIIC, alive, 454 days 1878.2
TCGA-04-1364-01A 61 years, female, white, stage:Stage IIIC, dead, 1024 days 1875.0
TCGA-13-1408-01A 59 years, female, white, stage:Stage IIIC, dead, 1680 days 1873.9
TCGA-24-2280-01A 74 years, female, white, stage:Stage IIIC, alive, 2143 days 1872.1
TCGA-20-1686-01A 75 years, female, white, stage:Stage IIIC, alive, 89 days 1863.8
TCGA-30-1857-01A 64 years, female, white, stage:Stage IV, dead, 8 days 1842.7
TCGA-24-1924-01A 65 years, female, white, stage:Stage IIIC, dead, 919 days 1832.8
TCGA-04-1519-01A 48 years, female, stage:Stage IIIC, alive, 24 days 1818.6
TCGA-25-2409-01A 71 years, female, white, stage:Stage IV, dead, 821 days 1815.9
TCGA-24-1428-01A 50 years, female, white, stage:Stage IIIC, alive, 529 days 1814.0
TCGA-13-0906-01A 50 years, female, white, stage:Stage IIIC, alive, 3619 days 1813.4
TCGA-59-2350-01A 44 years, female, stage:Stage IV, dead, 679 days 1811.6
TCGA-29-1697-01A 62 years, female, white, stage:Stage IIIC, dead, 949 days 1804.6
TCGA-25-1627-01A 73 years, female, white, stage:Stage IIIC, dead, 394 days 1803.0
TCGA-23-1030-01A 64 years, female, white, stage:Stage IIIC, alive, 886 days 1791.8
TCGA-24-1434-01A 59 years, female, white, stage:Stage IIIC, dead, 568 days 1791.4
TCGA-24-2024-01A 72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days 1791.3
TCGA-29-1705-01A 47 years, female, white, stage:Stage IIIC, dead, 555 days 1782.8
TCGA-29-1768-01A 50 years, female, white, stage:Stage IV, dead, 952 days 1774.9
TCGA-24-0968-01A 59 years, female, white, stage:Stage IIIC, dead, 598 days 1744.7
TCGA-29-1783-01A 58 years, female, white, stage:Stage IIIC, alive, 220 days 1743.6
TCGA-61-2109-01A 40 years, female, white, stage:Stage IIIC, dead, 629 days 1741.4
TCGA-23-1111-01A 63 years, female, white, stage:Stage IIIC, alive, 98 days 1741.2
TCGA-24-1435-01A 57 years, female, white, stage:Stage IIIC, dead, 1324 days 1725.0
TCGA-24-1419-01A 62 years, female, white, stage:Stage IIIC, alive, 239 days 1721.5
TCGA-24-1431-01A 67 years, female, white, stage:Stage IIIC, dead, 583 days 1719.7
TCGA-29-1784-01A 55 years, female, white, stage:Stage IIIC, alive, 163 days 1714.7
TCGA-24-1930-01A 53 years, female, white, stage:Stage IIIC, dead, 2467 days 1707.2
TCGA-13-0730-01A 71 years, female, white, stage:Stage IIIC, dead, 542 days 1707.1
TCGA-24-2023-01A 54 years, female, white, stage:Stage IIIA, dead, 1364 days 1706.2
TCGA-20-1682-01A 56 years, female, white, stage:Stage IIIC, alive, 837 days 1705.4
TCGA-24-1843-01A 66 years, female, white, stage:Stage IIIC, alive, 106 days 1701.9
TCGA-30-1860-01A 58 years, female, white, stage:Stage IIIC, dead, 1366 days 1699.6
TCGA-13-0920-01A 65 years, female, white, stage:Stage IIIC, dead, 1484 days 1695.4
TCGA-61-1907-01A 63 years, female, white, stage:Stage IIIC, alive, 952 days 1685.2
TCGA-13-2060-01A 51 years, female, white, stage:Stage IV, alive, 2369 days 1680.4
TCGA-25-2404-01A 38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days 1663.7
TCGA-13-0885-01A 70 years, female, white, stage:Stage IIIC, alive, 3388 days 1660.9
TCGA-24-2033-01A 87 years, female, white, stage:Stage IIIC, dead, 562 days 1658.2
TCGA-24-1413-01A 51 years, female, white, stage:Stage IIIC, alive, 192 days 1657.4
TCGA-36-1570-01A 49 years, female, white, stage:Stage IIIC, alive, 655 days 1652.5
TCGA-24-1616-01A 56 years, female, white, stage:Stage IIIC, dead, 1163 days 1649.4
TCGA-25-1312-01A 69 years, female, white, stage:Stage IV, dead, 31 days 1639.9
TCGA-36-1580-01A 82 years, female, stage:Stage IIIC, dead, 737 days 1633.3
TCGA-24-1565-01A 74 years, female, white, stage:Stage IIIC, dead, 312 days 1631.3
TCGA-13-1505-01A 63 years, female, white, stage:Stage IIIC, alive, 1998 days 1621.3
TCGA-24-1103-01A 50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days 1602.1
TCGA-23-1116-01A 83 years, female, white, stage:Stage IIIC, dead, 592 days 1598.8
TCGA-61-2092-01A 57 years, female, white, stage:Stage IIIC, alive, 1573 days 1597.3
TCGA-23-1122-01A 53 years, female, white, stage:Stage IIIC, dead, 1189 days 1592.8
TCGA-29-2427-01A 60 years, female, white, stage:Stage IIIC, alive, 1900 days 1587.7
TCGA-13-1499-01A 56 years, female, white, stage:Stage IIIC, alive, 3500 days 1583.7
TCGA-23-1023-01A 65 years, female, white, stage:Stage IIIC, alive, 1233 days 1576.1
TCGA-29-1762-01A 59 years, female, white, stage:Stage IV, dead, 2634 days 1575.0
TCGA-04-1362-01A 59 years, female, white, stage:Stage IIC, dead, 1348 days 1567.9
TCGA-24-1418-01A 68 years, female, white, stage:Stage IIIC, alive, 243 days 1566.2
TCGA-57-1585-01A 57 years, female, white, stage:Stage IIIC, dead, 53 days 1551.4
TCGA-30-1861-01A 74 years, female, white, stage:Stage IIIC, dead, 1058 days 1539.2
TCGA-24-1842-01A 49 years, female, white, stage:Stage IIIC, alive, 253 days 1537.2
TCGA-04-1331-01A 78 years, female, white, stage:Stage IIIC, dead, 1336 days 1531.9
TCGA-61-2098-01A 62 years, female, white, stage:Stage IIIC, alive, 1993 days 1491.7
TCGA-31-1959-01A 49 years, female, white, stage:Stage IV, alive, 67 days 1490.8
TCGA-29-1690-01A 66 years, female, white, stage:Stage IIIC, dead, 1448 days 1485.6
TCGA-24-1469-01A 71 years, female, white, stage:Stage IIIC, alive, 277 days 1485.1
TCGA-25-2398-01A 71 years, female, white, stage:Stage IIIC, dead, 1369 days 1483.5
TCGA-13-0886-01A 67 years, female, white, stage:Stage IIIC, alive, 4665 days 1481.8
TCGA-13-0800-01A 52 years, female, white, stage:Stage IIIC, alive, 2661 days 1461.8
TCGA-61-1918-01A 45 years, female, white, stage:Stage IV, dead, 479 days 1461.6
TCGA-25-2400-01A 76 years, female, white, stage:Stage IIIC, dead, 1278 days 1445.9
TCGA-24-1850-01A 72 years, female, white, stage:Stage IIIC, alive, 168 days 1436.9
TCGA-24-1844-01A 64 years, female, white, stage:Stage IIIC, alive, 113 days 1429.7
TCGA-29-1691-01A 51 years, female, white, stage:Stage IIIC, dead, 1470 days 1429.4
TCGA-61-2111-01A 61 years, female, white, stage:Stage IV, alive, 3825 days 1416.4
TCGA-61-1728-01A 59 years, female, white, stage:Stage IV, alive, 848 days 1396.1
TCGA-25-1631-01A 73 years, female, white, stage:Stage IIIC, dead, 9 days 1395.4
TCGA-29-1781-01A 69 years, female, white, stage:Stage IIIC, alive, 255 days 1393.4
TCGA-36-1568-01A 52 years, female, stage:Stage IIIC, alive, 875 days 1373.3
TCGA-WR-A838-01A 72 years, female, black or african american, stage:Stage IIIC, dead, 304 days 1370.3
TCGA-25-2399-01A 80 years, female, white, stage:Stage IIIC, dead, 608 days 1370.1
TCGA-24-1549-01A 58 years, female, white, stage:Stage IIIB, dead, 1721 days 1369.1
TCGA-29-1694-01A 45 years, female, white, stage:Stage IIIC, dead, 1187 days 1368.2
TCGA-61-1995-01A 43 years, female, white, stage:Stage IIIC, alive, 61 days 1365.2
TCGA-24-1417-01A 54 years, female, white, stage:Stage IV, alive, 238 days 1359.7
TCGA-25-1632-01A 68 years, female, white, stage:Stage IV, dead, 1799 days 1355.1
TCGA-30-1718-01A 44 years, female, white, stage:Stage IIIC, dead, 1579 days 1351.8
TCGA-29-1688-01A 39 years, female, white, stage:Stage IIIC, dead, 2400 days 1348.8
TCGA-13-0883-01A 61 years, female, white, stage:Stage IIIC, dead, 2097 days 1335.1
TCGA-13-0923-01A 74 years, female, white, stage:Stage IIIC, alive, 2547 days 1324.4
TCGA-13-0714-01A 55 years, female, white, stage:Stage IV, dead, 189 days 1321.4
TCGA-09-0366-01A 55 years, female, white, stage:Stage IIIC, dead, 1757 days 1311.2
TCGA-24-2254-01A 66 years, female, white, stage:Stage IIIC, dead, 1736 days 1308.5
TCGA-13-1501-01A 50 years, female, white, stage:Stage IV, dead, 1314 days 1307.7
TCGA-29-1770-01A 54 years, female, white, stage:Stage IIIC, alive, 741 days 1300.3
TCGA-57-1584-01A 47 years, female, white, stage:Stage IIIC, alive, 643 days 1299.6
TCGA-24-1474-01A 57 years, female, black or african american, stage:Stage IIIC, dead, 676 days 1298.1
TCGA-09-1666-01A 57 years, female, white, stage:Stage IIIC, alive, 1752 days 1281.2
TCGA-24-1467-01A 51 years, female, white, stage:Stage IIIC, dead, 3224 days 1278.3
TCGA-09-1673-01A 50 years, female, white, stage:Stage IV, alive, 92 days 1274.9
TCGA-29-1710-01A 54 years, female, white, stage:Stage IIIC, dead, 951 days 1263.5
TCGA-13-1483-01A 61 years, female, white, stage:Stage IIIC, dead, 895 days 1261.4
TCGA-23-1110-01A 42 years, female, white, stage:Stage IIIC, alive, 1658 days 1261.0
TCGA-24-1416-01A 34 years, female, white, stage:Stage IV, alive, 194 days 1258.2
TCGA-29-1695-01A 62 years, female, white, stage:Stage IIIC, dead, 1229 days 1257.8
TCGA-24-1928-01A 77 years, female, white, stage:Stage IIIC, dead, 336 days 1235.3
TCGA-20-1683-01A 65 years, female, white, stage:Stage IIIC, alive, 772 days 1233.2
TCGA-57-1583-01A 57 years, female, black or african american, stage:Stage IIIC, dead, 346 days 1230.9
TCGA-36-1574-01A 48 years, female, asian, stage:Stage IIIC, alive, 686 days 1228.6
TCGA-25-1320-01A 65 years, female, white, stage:Stage IIIC, dead, 1155 days 1226.9
TCGA-24-2020-01A 67 years, female, white, stage:Stage IIIC, dead, 4624 days 1222.6
TCGA-30-1862-01A 65 years, female, white, stage:Stage IV, dead, 186 days 1216.4
TCGA-59-2354-01A 63 years, female, white, stage:Stage IIIC, dead, 1046 days 1214.1
TCGA-57-1582-01A 50 years, female, white, stage:Stage IIIC, dead, 731 days 1213.9
TCGA-09-2054-01A 58 years, female, black or african american, stage:Stage IIIC, dead, 637 days 1211.6
TCGA-25-2401-01A 64 years, female, white, stage:Stage IIIC, dead, 90 days 1207.7
TCGA-31-1956-01A 60 years, female, white, stage:Stage IIIB, alive, 1342 days 1201.7
TCGA-61-2101-01A 55 years, female, white, stage:Stage IIIC, dead, 1688 days 1194.3
TCGA-25-1328-01A 38 years, female, white, stage:Stage IIIC, dead, 2009 days 1187.5
TCGA-13-1410-01A 57 years, female, white, stage:Stage IV, alive, 2464 days 1187.4
TCGA-59-2351-01A 51 years, female, white, stage:Stage IIIC, alive, 3532 days 1171.8
TCGA-61-1900-01A 51 years, female, black or african american, stage:Stage IIIB, alive, 176 days 1171.3
TCGA-24-1847-01A 45 years, female, white, stage:Stage IV, alive, 343 days 1169.4
TCGA-29-A5NZ-01A 66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days 1166.8
TCGA-24-1104-01A 56 years, female, white, stage:Stage IV, dead, 1933 days 1165.2
TCGA-24-1558-01A 73 years, female, white, stage:Stage IIIC, dead, 594 days 1160.2
TCGA-25-1633-01A 64 years, female, white, stage:Stage IIIC, dead, 1891 days 1157.6
TCGA-24-2298-01A 55 years, female, white, stage:Stage IIIC, dead, 1620 days 1157.2
TCGA-13-1492-01A 66 years, female, white, stage:Stage IIIC, dead, 3819 days 1156.5
TCGA-25-1628-01A 67 years, female, white, stage:Stage IIIC, dead, 627 days 1154.1
TCGA-25-1326-01A 61 years, female, white, stage:Stage IIIC, dead, 1249 days 1148.0
TCGA-24-2261-01A 76 years, female, white, stage:Stage IIIC, dead, 24 days 1145.8
TCGA-61-2097-01A 71 years, female, white, stage:Stage IIC, alive, 1844 days 1135.3
TCGA-29-1774-01A 82 years, female, white, stage:Stage IIIC, alive, 527 days 1134.4
TCGA-31-1950-01A 76 years, female, white, stage:Stage IIIC, alive, 571 days 1125.5
TCGA-09-2045-01A 50 years, female, asian, stage:Stage IV, dead, 1069 days 1116.7
TCGA-13-1403-01A 48 years, female, white, stage:Stage IIIC, dead, 2345 days 1115.7
TCGA-13-1512-01A 49 years, female, white, stage:Stage IIIC, alive, 442 days 1111.0
TCGA-31-1951-01A 58 years, female, white, stage:Stage IIIC, alive, 684 days 1110.3
TCGA-61-2102-01A 74 years, female, white, stage:Stage IIIC, dead, 197 days 1099.9
TCGA-24-2290-01A 56 years, female, white, stage:Stage IIIC, dead, 1102 days 1096.5
TCGA-31-1944-01A 47 years, female, white, stage:Stage IIIC, alive, 1386 days 1088.0
TCGA-57-1994-01A 63 years, female, white, stage:'--, alive, 761 days 1083.2
TCGA-25-1315-01A 50 years, female, white, stage:Stage IIIC, dead, 1583 days 1077.1
TCGA-04-1332-01A 70 years, female, white, stage:Stage IIIC, dead, 1247 days 1070.8
TCGA-30-1866-01A 61 years, female, white, stage:Stage IV, dead, 1114 days 1069.7
TCGA-13-0720-01A 48 years, female, white, stage:Stage IIIC, dead, 1355 days 1030.0
TCGA-13-0797-01A 49 years, female, white, stage:Stage IIIC, alive, 2121 days 1029.4
TCGA-24-1604-01A 66 years, female, white, stage:Stage IIIC, dead, 2688 days 1017.5
TCGA-61-2003-01A 53 years, female, white, stage:Stage IIIC, alive, 122 days 1014.8
TCGA-25-1630-01A 73 years, female, white, stage:Stage IIIC, dead, 1162 days 1012.4
TCGA-24-2035-01A 65 years, female, white, stage:Stage IIIC, dead, 857 days 1011.2
TCGA-57-1993-01A 56 years, female, white, stage:Stage IIIC, alive, 763 days 1011.1
TCGA-13-1405-01A 49 years, female, white, stage:Stage IV, dead, 868 days 1006.1
TCGA-25-1313-01A 62 years, female, white, stage:Stage IV, dead, 820 days 1001.2
TCGA-24-1552-01A 77 years, female, white, stage:Stage IIIC, dead, 1259 days 993.9
TCGA-04-1648-01A 57 years, female, white, stage:Stage IIIC, dead, 871 days 988.0
TCGA-29-1711-01A 45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days 979.6
TCGA-24-2026-01A 79 years, female, white, stage:Stage IIIC, dead, 1059 days 979.5
TCGA-24-2267-01A 58 years, female, white, stage:Stage IIB, dead, 1446 days 973.1
TCGA-24-1422-01A 82 years, female, black or african american, stage:Stage IIIC, dead, 23 days 962.5
TCGA-23-1123-01A 59 years, female, white, stage:Stage IIIC, dead, 1018 days 960.4
TCGA-24-1427-01A 58 years, female, stage:Stage IIIC, alive, 147 days 958.8
TCGA-61-1919-01A 58 years, female, white, stage:Stage IIIC, dead, 1161 days 953.1
TCGA-24-1423-01A 61 years, female, white, stage:Stage IIIC, alive, 190 days 943.3
TCGA-24-1551-01A 53 years, female, white, stage:Stage IIIC, dead, 1579 days 939.3
TCGA-24-1424-01A 67 years, female, white, stage:Stage IIIC, alive, 183 days 931.4
TCGA-23-1809-01A 63 years, female, white, stage:Stage IIC, alive, 16 days 930.1
TCGA-29-1763-01A 43 years, female, black or african american, stage:Stage IIC, alive, 2032 days 911.7
TCGA-59-2352-01A 78 years, female, white, stage:Stage IIIC, dead, 286 days 911.0
TCGA-24-2281-01A 68 years, female, white, stage:Stage IIA, alive, 1357 days 907.9
TCGA-20-0987-01A 61 years, female, white, stage:Stage IIIC, dead, 701 days 907.5
TCGA-24-2271-01A 55 years, female, asian, stage:Stage IIIC, dead, 962 days 904.8
TCGA-36-1576-01A 76 years, female, stage:Stage IIIC, alive, 915 days 895.4
TCGA-23-2078-01A 66 years, female, white, stage:Stage IIIC, alive, 2661 days 881.3
TCGA-09-1662-01A 58 years, female, white, stage:Stage IV, dead, 2717 days 880.5
TCGA-25-1623-01A 71 years, female, white, stage:Stage IV, dead, 565 days 878.2
TCGA-24-2036-01A 50 years, female, white, stage:Stage IIIA, dead, 1947 days 857.6
TCGA-24-1603-01A 53 years, female, white, stage:Stage IIIB, dead, 2742 days 857.6
TCGA-13-0768-01A 73 years, female, white, stage:Stage IIIC, dead, 1784 days 856.5
TCGA-24-1563-01A 66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days 851.1
TCGA-36-1571-01A 53 years, female, white, stage:Stage IIIB, dead, 695 days 845.8
TCGA-13-0916-01A 49 years, female, white, stage:Stage IIIC, alive, 1785 days 845.4
TCGA-13-1411-01A 81 years, female, white, stage:Stage IIIC, dead, 531 days 839.1
TCGA-23-1120-01A 60 years, female, white, stage:Stage IIIC, alive, 130 days 835.7
TCGA-61-1910-01A 56 years, female, white, stage:Stage IIC, alive, 1127 days 812.5
TCGA-24-1430-01A 68 years, female, white, stage:Stage IIIC, dead, 863 days 808.0
TCGA-25-1635-01A 71 years, female, white, stage:Stage IIIC, dead, 1583 days 806.6
TCGA-25-1626-01A 65 years, female, white, stage:Stage IIIC, dead, 518 days 795.5
TCGA-13-1485-01A 48 years, female, white, stage:Stage IV, dead, 629 days 792.7
TCGA-23-2084-01A 45 years, female, white, stage:Stage IV, dead, 1516 days 781.7
TCGA-24-2293-01A 47 years, female, white, stage:'--, dead, 506 days 766.2
TCGA-31-1953-01A 52 years, female, asian, stage:Stage IIIC, alive, 204 days 740.1
TCGA-13-A5FT-01A 67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days 738.7
TCGA-24-2297-01A 56 years, female, white, stage:Stage IIIC, dead, 1699 days 738.4
TCGA-24-2288-01A 70 years, female, white, stage:Stage IIIC, dead, 25 days 731.3
TCGA-25-1319-01A 73 years, female, white, stage:Stage IIIC, dead, 1977 days 730.0
TCGA-61-1738-01A 60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days 727.8
TCGA-25-1321-01A 65 years, female, white, stage:Stage IIIC, dead, 1033 days 722.1
TCGA-61-2113-01A 53 years, female, white, stage:Stage IIC, dead, 676 days 713.2
TCGA-36-1581-01A 63 years, female, white, stage:Stage IIC, alive, 751 days 706.6
TCGA-61-1737-01A 42 years, female, white, stage:Stage IV, alive, 1364 days 699.4
TCGA-04-1361-01A 57 years, female, white, stage:Stage IIIB, alive, 989 days 697.5
TCGA-25-1329-01A 76 years, female, white, stage:Stage IIIC, dead, 457 days 697.3
TCGA-13-1511-01A 52 years, female, asian, stage:Stage IV, dead, 1650 days 696.3
TCGA-24-1105-01A 36 years, female, white, stage:Stage IIIC, dead, 1442 days 694.6
TCGA-61-2012-01A 81 years, female, white, stage:Stage IIC, alive, 932 days 671.4
TCGA-24-2027-01A 51 years, female, white, stage:Stage IV, dead, 3337 days 669.4
TCGA-29-1785-01A 55 years, female, white, stage:Stage IIIC, dead, 1104 days 660.6
TCGA-61-2088-01A 51 years, female, white, stage:Stage IIIC, alive, 145 days 650.7
TCGA-04-1536-01A 60 years, female, black or african american, stage:Stage IV, dead, 885 days 631.5
TCGA-25-2392-01A 75 years, female, white, stage:Stage IV, dead, 31 days 624.8
TCGA-24-1425-01A 45 years, female, white, stage:Stage IIIC, alive, 181 days 616.5
TCGA-61-2104-01A 53 years, female, white, stage:Stage IIC, alive, 2338 days 592.7
TCGA-24-1546-01A 46 years, female, white, stage:Stage IIIC, dead, 1955 days 587.3
TCGA-25-1322-01A 62 years, female, white, stage:Stage IV, dead, 91 days 542.1
TCGA-25-1318-01A 54 years, female, white, stage:Stage IIIC, dead, 1064 days 488.8
TCGA-24-2289-01A 68 years, female, white, stage:Stage IV, dead, 2049 days 478.4
TCGA-25-2042-01A 60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days 417.4
TCGA-04-1514-01A 45 years, female, white, stage:Stage IIIA, dead, 1720 days 299.3
TCGA-24-1557-01A 49 years, female, white, stage:Stage IIIC, dead, 1213 days 228.2
TCGA-59-2348-01A 59 years, female, white, stage:Stage IIIC, alive, 5481 days 221.0
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

RPL35A is not prognostic in Ovary Serous Cystadenocarcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 2964.05
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 2406.8
Number of samples 81
Samples
Sample Description pTPM
DO46356 68 years, female, NA, stage:III, dead, 911 days 5669.9
DO46370 54 years, female, NA, stage:III, dead, 1727 days 5438.5
DO46561 52 years, female, NA, stage:III, dead, 195 days 4740.4
DO46338 59 years, female, NA, stage:III, dead, 596 days 4569.1
DO46333 58 years, female, NA, stage:III, dead, 359 days 4312.7
DO46591 58 years, female, NA, stage:III, dead, 195 days 4303.6
DO46581 66 years, female, NA, stage:III, dead, 408 days 4220.6
DO46576 75 years, female, NA, stage:III, alive, 133 days 4060.3
DO46597 60 years, female, NA, stage:III, dead, 393 days 3838.2
DO46384 55 years, female, NA, stage:III, dead, 614 days 3655.3
DO46402 77 years, female, NA, stage:III, dead, 511 days 3442.2
DO46342 67 years, female, NA, stage:III, dead, 1398 days 3422.6
DO46360 58 years, female, NA, stage:IV, dead, 1759 days 3322.1
DO46551 58 years, female, NA, stage:III, dead, 1055 days 3290.2
DO46364 45 years, female, NA, stage:III, dead, 806 days 3276.1
DO46586 55 years, female, NA, stage:III, dead, 1019 days 3103.9
DO46380 51 years, female, NA, stage:III, dead, 1423 days 3025.1
DO46568 66 years, female, NA, stage:III, dead, 320 days 3005.1
DO46400 70 years, female, NA, stage:III, dead, 719 days 2976.7
DO46463 49 years, female, NA, stage:III, dead, 2451 days 2951.4
DO46352 60 years, female, NA, stage:III, dead, 677 days 2934.2
DO46331 72 years, female, NA, stage:III, dead, 612 days 2926.7
DO46523 52 years, female, NA, stage:IV, alive, 1873 days 2925.7
DO46330 60 years, female, NA, stage:III, dead, 684 days 2910.0
DO46334 77 years, female, NA, stage:III, dead, 496 days 2860.9
DO46528 56 years, female, NA, stage:III, alive, 6139 days 2790.0
DO46392 48 years, female, NA, stage:III, dead, 628 days 2782.9
DO46390 65 years, female, NA, stage:III, dead, 374 days 2748.2
DO46566 78 years, female, NA, stage:III, dead, 673 days 2722.7
DO46438 55 years, female, NA, stage:IV, alive, 2227 days 2715.6
DO46606 73 years, female, NA, stage:III, alive, 804 days 2681.0
DO46508 50 years, female, NA, stage:III, dead, 2101 days 2604.3
DO46588 74 years, female, NA, stage:III, dead, 438 days 2525.3
DO46560 45 years, female, NA, stage:IV, dead, 286 days 2484.2
DO46366 65 years, female, NA, stage:III, dead, 2054 days 2443.6
DO46394 61 years, female, NA, stage:IV, dead, 1039 days 2428.1
DO46398 66 years, female, NA, stage:III, alive, 437 days 2423.2
DO46448 45 years, female, NA, stage:III, dead, 654 days 2417.4
DO46396 64 years, female, NA, stage:III, dead, 583 days 2413.6
DO46346 54 years, female, NA, stage:III, dead, 1187 days 2398.9
DO46404 55 years, female, NA, stage:III, dead, 690 days 2371.3
DO46362 61 years, female, NA, stage:III, dead, 1639 days 2306.3
DO46443 59 years, female, NA, stage:III, dead, 2464 days 2284.9
DO46436 58 years, female, NA, stage:III, alive, 3193 days 2226.9
DO46571 61 years, female, NA, stage:III, dead, 243 days 2188.8
DO46326 51 years, female, NA, stage:III, dead, 701 days 2169.8
DO46378 59 years, female, NA, stage:III, alive, 843 days 2008.1
DO46354 73 years, female, NA, stage:III, dead, 843 days 1960.2
DO46374 69 years, female, NA, stage:III, dead, 1409 days 1941.1
DO46368 57 years, female, NA, stage:III, dead, 2879 days 1932.4
DO46327 54 years, female, NA, stage:III, dead, 184 days 1930.3
DO46376 58 years, female, NA, stage:III, dead, 1430 days 1907.2
DO46458 67 years, female, NA, stage:IV, alive, 3787 days 1872.2
DO46350 66 years, female, NA, stage:III, dead, 886 days 1836.6
DO46358 60 years, female, NA, stage:III, dead, 423 days 1815.3
DO46408 56 years, female, NA, stage:III, dead, 489 days 1781.6
DO46325 54 years, female, NA, stage:III, dead, 477 days 1750.2
DO46602 74 years, female, NA, stage:III, dead, 205 days 1720.8
DO46432 56 years, female, NA, stage:III, alive, 2218 days 1683.8
DO46386 49 years, female, NA, stage:III, dead, 1162 days 1676.4
DO46412 64 years, female, NA, stage:III, dead, 597 days 1591.6
DO46332 56 years, female, NA, stage:III, dead, 689 days 1565.0
DO46340 62 years, female, NA, stage:III, dead, 616 days 1532.7
DO46328 52 years, female, NA, stage:III, dead, 972 days 1514.4
DO46611 52 years, female, NA, stage:III, dead, 734 days 1471.3
DO46493 62 years, female, NA, stage:IV, alive, 839 days 1463.7
DO46468 67 years, female, NA, stage:III, alive, 2776 days 1407.4
DO46336 70 years, female, NA, stage:IV, dead, 664 days 1394.6
DO46348 58 years, female, NA, stage:IV, dead, 287 days 1361.9
DO46453 66 years, female, NA, stage:III, dead, 3294 days 1327.6
DO46372 39 years, female, NA, stage:III, dead, 1326 days 1314.3
DO46388 74 years, female, NA, stage:III, dead, 413 days 1241.2
DO46329 52 years, female, NA, stage:III, dead, 1699 days 1181.7
DO46533 46 years, female, NA, stage:III, alive, 3667 days 1161.4
DO46344 46 years, female, NA, stage:III, dead, 642 days 1155.7
DO46518 62 years, female, NA, stage:III, alive, 2960 days 1127.7
DO46382 62 years, female, NA, stage:IV, dead, 311 days 941.2
DO46546 73 years, female, NA, stage:III, dead, 1889 days 928.9
DO46513 54 years, female, NA, stage:IV, dead, 1883 days 854.7
DO46538 57 years, female, NA, stage:III, dead, 1527 days 781.6
DO46428 59 years, female, NA, stage:IV, alive, 2644 days 512.9
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples 108
Samples
Sample ID Sample type nRPX
a03d1103-b809-42c4-ad5c-5aff58_D2 Tumor 1.6
256ac9f5-1e19-44b4-92fb-fef3fc_D2 Tumor 1.6
3a380577-c134-47ba-a1ce-988d7c_D2 Tumor 1.5
7069e990-4a4e-4984-a66d-4d835a_D2 Tumor 1.5
76e77c6b-c80e-4391-bdbb-e1dcea_D2 Tumor 1.4
627e6e36-3dca-4ee5-9755-6f3510_D2 Tumor 1.4
2563cb02-d58a-4286-8634-7502cd_D2 Tumor 1.3
15524912-685a-47ce-a824-567848_D2 Tumor 1.3
a8853382-b726-4ce8-98d5-ca89df_D2 Tumor 1.2
318d53c3-216b-4de1-a098-77d6dd_D2 Tumor 1.2
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2 Tumor 1.2
3d3e1888-d67e-4c69-ba83-112d0f_D2 Tumor 1.1
d38f40fb-dd78-43b2-8b7b-4b6977_D2 Tumor 1.1
28d0abdb-f682-4bd3-9425-a9c508_D2 Tumor 1.1
50997c44-1c8b-4d34-b535-4a6cc2_D2 Tumor 1.1
2433b136-fc7b-4cea-b958-bc6efb_D2 Tumor 1.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2 Tumor 1.0
9c8e78bf-b03e-4ba0-9909-5ff070_D2 Tumor 1.0
41d0619e-b299-42e2-ac32-29e784_D2 Tumor 1.0
eb0a53df-7620-4024-8d2d-051142_D2 Tumor 1.0
af95e2c6-25c4-4ab8-bf06-3e15ff_D2 Tumor 1.0
79b60f32-6cca-4cb6-9a1e-22a3ac_D2 Tumor 1.0
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2 Tumor 1.0
9b90eb78-2f50-4aeb-b010-d642f9_D2 Tumor 1.0
4ccb249a-6722-491e-97e9-e3b4e7_D2 Tumor 1.0
f6c215ea-5381-4521-bb61-be8e97_D2 Tumor 0.9
285fed94-1495-448e-879b-b55de9_D2 Tumor 0.9
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2 Tumor 0.9
e9d416e7-f661-400a-896e-388545_D2 Tumor 0.9
558333b0-ea23-4303-9e3c-4932b1_D2 Tumor 0.9
1c9145ad-1981-4871-aa7e-8b11de_D2 Tumor 0.9
0cc794c3-5bf5-4621-b238-58a0f6_D2 Tumor 0.9
161317f3-1a39-438e-af45-cd2502_D2 Tumor 0.9
10c2d629-0287-4511-ac25-f29031_D2 Tumor 0.9
1772e913-f62e-446a-8cf3-720348_D2 Tumor 0.9
d109a3c0-350e-47f5-bda0-61899c_D2 Tumor 0.9
5ea22f5e-307b-491d-801f-8b7fa6_D2 Tumor 0.9
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2 Tumor 0.9
3490835c-c004-45ed-91f3-7c206f_D2 Tumor 0.9
52c064a7-78d9-4a1a-85b4-27c6d1_D2 Tumor 0.9
2f901c90-617e-46da-9fac-d68369_D2 Tumor 0.8
347e379b-77c0-4dd3-aa25-18c9d1_D2 Tumor 0.8
91b287fd-eadb-442d-abcd-20b741_D2 Tumor 0.8
62f5840e-6cd7-4200-b651-645e53_D2 Tumor 0.8
46c73531-f531-4ec3-97fe-b39d9d_D2 Tumor 0.8
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2 Tumor 0.8
9e0d47e0-f633-468b-b82b-4d752d_D2 Tumor 0.8
1a10c200-3895-4648-b951-94f99f_D2 Tumor 0.7
fe83e13f-9754-403b-8f74-d6caf8_D2 Tumor 0.7
3946a96c-e0ae-442f-83b4-a9350e_D2 Tumor 0.7
fbb41c94-aabd-49cc-90b2-882c3e_D2 Tumor 0.7
27f3ca2d-a86f-479d-8e7e-5307c7_D2 Tumor 0.7
69d552be-7cb2-4bb4-b602-a27b3e_D2 Tumor 0.7
6530147a-efe9-4df6-ac2f-03ece3_D2 Tumor 0.7
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2 Tumor 0.6
8d78194e-fbef-4819-a7b5-b73ae9_D2 Tumor 0.6
d4791079-c826-4fc7-9d9b-ee20ba_D2 Tumor 0.6
2224c03f-b7b1-4368-887e-2b4cdf_D2 Tumor 0.6
5c3971ee-87c7-4dff-b66e-f18892_D2 Tumor 0.6
49bd51fe-48a1-4828-b66e-b30c38_D2 Tumor 0.6
2115808b-6a0d-49bc-a8d7-b83bde_D2 Tumor 0.6
c17b0ff9-9057-4848-a0cc-abb25f_D2 Tumor 0.5
092af714-b97a-457c-b0e9-8c20e8_D2 Normal 0.5
7d953d1d-84b6-4ecd-b1d7-1ed865_D2 Tumor 0.5
927f0958-db5a-4bc5-92b7-2a3695_D2 Tumor 0.5
51a4ce2f-4166-4c6b-a7e0-942d0a_D2 Tumor 0.5
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2 Tumor 0.4
340a3769-3031-41ae-bb08-a2f696_D2 Normal 0.4
1556af7e-c2ae-4fce-9aae-87c459_D1_D2 Normal 0.4
80873a0c-1f40-4d51-bab1-3f2071_D2 Tumor 0.4
35a345a4-e954-4c81-ae3f-7797cd_D2 Tumor 0.4
bd266bdd-12e4-42cb-9c49-911bfc_D2 Tumor 0.3
2b4ce90c-8036-4207-ac3e-54a76f_D2 Tumor 0.3
42d860a3-8a0c-4c44-a09a-9ad8cf_D2 Tumor 0.3
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2 Tumor 0.3
8e17b45e-6a06-4e4e-913d-7b1edb_D2 Tumor 0.3
05387aad-2a1f-42c2-8d6f-950598_D3 Tumor 0.1
08296da7-70ea-44df-8646-09f2cc_D2 Tumor 0.1
31c15e30-21d4-4843-bd4a-9cd0d8_D2 Normal 0.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3 Tumor 0.1
e3ebe010-cd31-4b5d-8fcb-b7103b_D2 Tumor 0.1
6319b36b-533c-4e86-8e12-80552e_D3 Tumor 0.0
3fbf076a-824b-4eac-b6dc-bf5e59_D2 Normal 0.0
61f76fe6-a1c6-41b8-bdc2-2f9209_D2 Normal 0.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2 Tumor 0.0
efc971f8-54c5-4531-a792-705ecf_D2 Tumor 0.0
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2 Tumor -0.1
2b73e01c-347a-4dae-a71d-752aeb_D2 Normal -0.1
eb3f3494-7057-4afe-b212-e6e9a3_D2 Tumor -0.2
0c87932d-b6fd-4eb5-b86a-a34d07_D2 Tumor -0.2
e6850782-fd2a-4c53-b682-1852fe_D2 Tumor -0.2
1db5574d-aca7-403c-8100-6e705f_D2 Normal -0.2
3e746bea-ed68-40e6-b348-6ddf08_D2 Normal -0.3
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2 Normal -0.3
b9c1f22e-61f7-45ed-b3b4-5094c7_D2 Normal -0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2 Normal -0.5
a65d8e76-640f-4341-a561-afbb57_D2 Normal -0.5
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2 Normal -0.7
0745488e-0bfb-4d1f-8228-dedf76_D1_D2 Normal -0.7
e23eb014-69c1-460a-b9d4-9786c8_D2 Normal -0.7
b22659b9-e12c-4725-a7db-a833de_D1_D2 Normal -0.7
7edfd606-4bee-4529-9fec-1ca7f0_D2 Normal -0.8
a3a26070-fb84-406a-8280-d555e6_D2 Normal -0.8
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2 Normal -0.9
21efd60f-6a31-4b98-9477-16a905_D2 Normal -0.9
994f9b8e-46cb-413f-8ec8-2c2fed_D2 Normal -1.1
2ed8beb2-bc63-4bad-b5fe-1916a0_D2 Tumor -1.1
a583d3ff-8165-43e9-b764-23b7ef_D1_D2 Normal -1.3
Show allShow less
OVARIAN CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Pending cancer tissue analysis

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org